Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

BUY
$88.75 - $119.95 $85,732 - $115,871
966 New
966 $115,000
Q3 2020

Nov 13, 2020

SELL
$75.65 - $93.58 $54,770 - $67,751
-724 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$84.96 - $118.91 $61,511 - $86,090
724 New
724 $65,000
Q1 2019

May 15, 2019

SELL
$83.25 - $102.12 $2,414 - $2,961
-29 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$90.66 - $116.63 $2,629 - $3,382
29 New
29 $3,000
Q3 2018

Nov 14, 2018

SELL
$89.96 - $114.58 $11,334 - $14,437
-126 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$71.53 - $95.75 $9,012 - $12,064
126 New
126 $11,000
Q1 2018

May 15, 2018

SELL
$60.72 - $74.41 $489,646 - $600,042
-8,064 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$44.96 - $58.99 $362,557 - $475,695
8,064
8,064 $468,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.58B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.